FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

7591911000001108: DepoCyte 50mg/5ml intrathecal suspension for injection vials (Napp Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
20430501000001115 DepoCyte 50mg/5ml intrathecal suspension for injection vials (Napp Pharmaceuticals Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
39168701000001117 DepoCyte 50mg/5ml suspension for injection vials (Napp Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
DepoCyte 50mg/5ml intrathecal suspension for injection vials (Napp Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
DepoCyte 50mg/5ml intrathecal suspension for injection vials (Napp Pharmaceuticals Ltd) Is a Cytarabine 50mg/5ml intrathecal suspension for injection vials true Inferred relationship Existential restriction modifier
DepoCyte 50mg/5ml intrathecal suspension for injection vials (Napp Pharmaceuticals Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
DepoCyte 50mg/5ml intrathecal suspension for injection vials (Napp Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
DepoCyte 50mg/5ml intrathecal suspension for injection vials (Napp Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
DepoCyte 50mg/5ml intrathecal suspension for injection vials (Napp Pharmaceuticals Ltd) Has active ingredient Cytarabine false Inferred relationship Existential restriction modifier
DepoCyte 50mg/5ml intrathecal suspension for injection vials (Napp Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
DepoCyte 50mg/5ml intrathecal suspension for injection vials (Napp Pharmaceuticals Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
DepoCyte 50mg/5ml intrathecal suspension for injection vials (Napp Pharmaceuticals Ltd) Has manufactured dose form Conventional release suspension for injection false Inferred relationship Existential restriction modifier
DepoCyte 50mg/5ml intrathecal suspension for injection vials (Napp Pharmaceuticals Ltd) Is a DepoCyte true Inferred relationship Existential restriction modifier
DepoCyte 50mg/5ml intrathecal suspension for injection vials (Napp Pharmaceuticals Ltd) Has specific active ingredient Cytarabine false Inferred relationship Existential restriction modifier
DepoCyte 50mg/5ml intrathecal suspension for injection vials (Napp Pharmaceuticals Ltd) Has active ingredient Cytarabine liposome true Inferred relationship Existential restriction modifier
DepoCyte 50mg/5ml intrathecal suspension for injection vials (Napp Pharmaceuticals Ltd) Has dispensed dose form Conventional release suspension for injection true Inferred relationship Existential restriction modifier
DepoCyte 50mg/5ml intrathecal suspension for injection vials (Napp Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
DepoCyte 50mg/5ml intrathecal suspension for injection vials (Napp Pharmaceuticals Ltd) Has manufactured dose form Conventional release suspension for injection true Inferred relationship Existential restriction modifier
DepoCyte 50mg/5ml intrathecal suspension for injection vials (Napp Pharmaceuticals Ltd) Has specific active ingredient Cytarabine liposomal pegylated true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
DepoCyte 50mg/5ml intrathecal suspension for injection vials (Napp Pharmaceuticals Ltd) 1 vial Is pack of False DepoCyte 50mg/5ml intrathecal suspension for injection vials (Napp Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier
DepoCyte 50mg/5ml intrathecal suspension for injection vials (Napp Pharmaceuticals Ltd) 1 vial Has AMP True DepoCyte 50mg/5ml intrathecal suspension for injection vials (Napp Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start